Bain Capital
http://www.baincapital.comBain Capital, LLC is a global private investment firm that manages several pools of capital including private equity, venture capital, public equity and leveraged debt assets with more than $65 billion in assets under management. Since its inception in 1984, Bain Capital has made private equity investments and add-on acquisitions in more than 300 companies in a variety of industries around the world, and has a team of almost 300 professionals dedicated to investing in and supporting its portfolio companies, including such leading companies as Dunkin' Donuts, Michaels Stores and Domino's Pizza. Headquartered in Boston, Bain Capital has offices in New York, London, Munich, Hong Kong, Shanghai and Tokyo.
View Older Stories View More Recent Stories
-
Variational Secures ~$50M to Bring Liquidity from Traditional Markets To Crypto
-
JenaValve Appoints Tonya Porter as Vice President of Regulatory Affairs
-
VXI Receives Frost & Sullivan's 2026 North America Company of the Year for Excellence in Revenue Generating Solutions Leadership
-
Google DeepMind hires staff from Contextual AI in licensing deal, source says
-
Norm Law Adds Veteran Corporate Transactions Partner James Gerkis
-
GraniteShares Expands Autocallable ETF Lineup with Launch of PLTR and HOOD ETFs
-
Rapid Micro Biosystems prices $9.8 million stock and warrant offering
-
Rapid Micro Biosystems Announces Pricing of Up to Approximately $32 Million Underwritten Offering
-
Form SCHEDULE 13G/A Lincoln Bain Capital Filed by: LVIP GLOBAL GROWTH ALLOCATION MANAGED RISK FUND
-
Form SCHEDULE 13D/A Lincoln Bain Capital Filed by: LINCOLN NATIONAL CORP
-
Form 4 Lincoln Bain Capital For: May 14 Filed by: Lincoln Financial Investments Corp
-
ADGM Strengthens Position as MEASA's Leading IFC With 57% Growth in AUM, over 13,000 Active Licences in Q1 2026
-
Form SCHEDULE 13G/A Olema Pharmaceuticals, Filed by: Bain Capital Life Sciences Opportunities IV, L.P.
-
Form SCHEDULE 13G/A Xilio Therapeutics, Inc. Filed by: Bain Capital Life Sciences Fund II, L.P.
-
Form 13F-NT Bain Capital Life Scienc For: Mar 31
-
Form 13F-NT Bain Capital Life Scienc For: Mar 31
-
Form 13F-NT Bain Capital Life Scienc For: Mar 31
-
Form 13F-NT Bain Capital Life Scienc For: Mar 31
-
Form 13F-NT Bain Capital Life Scienc For: Mar 31
-
Form 13F-NT Bain Capital Life Scienc For: Mar 31
-
Form 13F-NT Bain Capital Life Scienc For: Mar 31
-
Form 13F-HR Bain Capital Life Scienc For: Mar 31
-
Form 13F-NT Bain Capital Life Scienc For: Mar 31
-
Form 13F-NT Bain Capital Life Scienc For: Mar 31
-
Form 13F-NT Bain Capital Life Scienc For: Mar 31
-
Form 13F-NT Bain Capital Prairie For: Mar 31
-
Form 13F-NT Bain Capital Prairie For: Mar 31
-
Form 13F-HR Bain Capital Prairie, For: Mar 31
-
Form SCHEDULE 13G/A Bain Capital GSS Investm Filed by: Empyrean Capital Partners, LP
-
Form SCHEDULE 13G/A Bain Capital GSS Investm Filed by: Fort Baker Capital Management LP
-
Form 13F-NT Bain Capital Fund XII, For: Mar 31
-
Form 13F-NT Bain Capital Fund XI, For: Mar 31
-
Form 13F-HR BAIN CAPITAL INVESTORS For: Mar 31
-
Form 13F-NT Bain Capital Partners For: Mar 31
-
Form 13F-NT Bain Capital Venture For: Mar 31
-
Form 13F-NT Bain Capital Venture For: Mar 31
-
Form 13F-NT Bain Capital Venture For: Mar 31
-
Form 13F-HR BAIN CAPITAL VENTURE For: Mar 31
-
Form 13F-NT Bain Capital Venture For: Mar 31
-
Form 13F-NT Bain Capital Venture For: Mar 31
-
Form 13F-NT Bain Capital Venture For: Mar 31
-
Form 13F-NT Bain Capital Partners For: Mar 31
-
Form 13F-HR Bain Capital Public Equi For: Mar 31
-
Memory maker Kioxia sees $8.2 billion Q1 profit on AI boom
-
Form 13F-HR Bain Capital Credit, LP For: Mar 31
-
Form 13F-HR Bain Capital Public Equi For: Mar 31
-
Form 10-Q Bain Capital GSS Investm For: Mar 31
-
Form SCHEDULE 13G/A Bain Capital Private Filed by: Bain Capital Credit, LP
-
Form 10-Q Bain Capital Private For: Mar 31
-
KBW on Bain Capital Specialty Finance (BCSF): 'A stable quarter in a challenging backdrop'
